This report focuses on progress with responses to avian influenza and with pandemic preparedness between June 2007 and June 2008. Where data allow, the report looks back over the last three years. It also: 1) describes international financial …

This article, published in the Journal of Infectious Diseases, describes a novel cell culture-derived influenza vaccine (CCIV) produced in Madin-Darby canine kidney cells. The Phase 3, multicenter study in Poland observed that CCIV was well …

This article, published through Online First of the British Medical Journal, details a study wherein researchers evaluated the safety, tolerability, and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus …

This review, published in Nature Reviews Immunology, discusses gaps in the knowledge of how avian influenza viruses work in humans and the the status of influenza vaccine development as of 2007. It also provides a general overview of the features of …

This web page provides information and resources for health professionals and the public on preventing and controlling influenza.

This article, published in Vaccine, details the results of a survey of global influenza vaccine supply covering 157 countries from 2004 to 2009. The authors find that global annual vaccine provision increased 72 percent to 449 million doses during …

This document analyzes research and development activities for vaccines against infectious diseases of public health importance. Disease groups covered include diarrheal disease, sexually transmitted diseases, respiratory infections, bacterial …

This report focuses on the major developments in vaccines and immunization since 2000. Part 1 examines the impact of immunization on efforts to meet the Millennium Development Goals. It looks at the development and use of vaccines and the …

This study, published in the Journal of Infectious Diseases, assessed the safety, reactogenicity, and immunogenicity of an injectable cell culture-derived influenza vaccine, compared with those of an injectable egg-based trivalent inactivated …

These documents provide the latest stability data for commonly used vaccines and current research on vaccine formulations and platform technologies. Data are sorted by vaccine in a table format in both documents.

This article, published in Annual Review of Medicine, summarizes advances in the field of universal influenza vaccine development. It focuses on novel vaccine designs that have yielded promising preclinical and clinical data. ABSTRACT ONLY. (Learn …

This article, published by The New England Journal of Medicine, details the findings of a single-center study in the United Kingdom to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine, in both MF59-adjuvanted and …

This article, published in The New England Journal of Medicine, describes the methods, results, and conclusions from a single-center study to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine. The study, conducted in the …

This fact sheet describes a Phase 4, post-licensure influenza vaccine effectiveness study that PATH and its partners are conducting in Senegal. The study seeks to better understand the extent of the influenza disease burden in tropical Africa, …

This fact sheet explains what thimerosal is and why it is used as a preservative in some multi-dose vials of influenza vaccine, and highlights conclusions from studies examining thimerosal safety in vaccines.

This web page contains real-life accounts of people who have suffered or died from vaccine-preventable diseases, including compelling personal testimonies, remembrances, case reports, and newspaper articles.

This website provides information about the work of PATH’s Vaccine Development Global Program to improve the health of people, especially infants and children living in low-income countries, by accelerating the development of vaccines …

This website is a comprehensive and user-friendly source of scientifically accurate and easily navigable immunization information. The site offers parents, other adults, legislators, the media, and others a one-stop shop for learning about vaccines …

This web page provides links to all of the World Health Organization's position papers on specific vaccines. In addition to linking to these resources in English, it also provides links to translations of the papers into other languages, as well as …

For human vaccines to be available on a global scale, complex production methods, meticulous quality control, and reliable distribution channels are needed to ensure that the products are potent and effective at the point of use. In this article, …

Compiled by the Immunization Action Coalition, this web page provides a chronological compendium of selected peer-reviewed vaccine-related articles. A user can browse by topic areas such as vaccine safety, specific diseases, and people …

This updated position paper from the World Health Organization (WHO), published in the Weekly Epidemiological Record, recommends that countries considering the initiation or expansion of seasonal influenza vaccination programs give the highest …

This editorial, published in the journal Vaccine, discusses the importance of advances in influenza vaccines in light of the emergence of the avian influenza strain.

The Vaccines for Africa website is intended to be an interactive forum for the exchange of accurate, up-to-date, and evidence-based information on vaccines and immunization practices relevant to Africa, and to be a strategic resource for health …

This quarterly e-newsletter provides an update on PATH’s efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against the leading causes of childhood deaths in developing-world populations, pneumonia …